Filtros de búsqueda

Lista de obras de

A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease

scientific article published on 22 December 2019

An expert consensus to standardise the assessment of histological disease activity in Crohn's disease clinical trials

artículo científico publicado en 2021

Comparative outcomes in patients with ulcer- vs non-ulcer-related acute upper gastrointestinal bleeding in the United Kingdom: a nationwide cohort of 4474 patients

scientific article published on 09 January 2019

Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease

scientific article published on 13 July 2020

Comparison of infliximab with adalimumab in 827 biologic-naïve patients with Crohn's disease: a population-based Danish cohort study

artículo científico publicado en 2017

Early combined immunosuppression may be effective and safe in older patients with Crohn's disease: post hoc analysis of REACT

scientific article published on 19 March 2019

Editorial: combination immunosuppressive therapy to treat Crohn's disease - ready for all age groups? Authors' reply

scientific article published on 01 June 2019

Editorial: is age just a number when it comes to treatment of inflammatory bowel disease?

scientific article published on 01 November 2020

Editorial: pancreatic cancer risk in inflammatory bowel diseases-it's all relative

artículo científico publicado en 2020

Editorial: predicting recurrence of Crohn's disease after surgical resection-close to a crystal ball

artículo científico publicado en 2018

Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn's disease

scientific article published on 24 April 2020

Evaluating the optimum number of biopsies to assess histological inflammation in ulcerative colitis: a retrospective cohort study

scientific article published on 27 September 2020

High body mass index is associated with increased risk of treatment failure and surgery in biologic-treated patients with ulcerative colitis

artículo científico publicado en 2018

Letter: combination of biologics in inflammatory bowel diseases. Authors' reply

scientific article published on 01 August 2020

Letter: immunogenicity of anti-TNF in elderly IBD patients-authors' reply

scientific article published on 01 August 2019

Letter: pre-operative anti-TNF therapy in Crohn's disease is not associated with increased complications following elective surgery

artículo científico publicado en 2019

No benefit of continuing vs stopping 5-aminosalicylates in patients with ulcerative colitis escalated to anti-metabolite therapy

artículo científico publicado en 2020

Predictors and outcomes of histological remission in ulcerative colitis treated to endoscopic healing

scientific article published on 09 August 2020

Prevalence of endoscopic improvement and remission according to patient-reported outcomes in ulcerative colitis

scientific article published on 22 November 2019

Risk of de-novo inflammatory bowel disease among obese patients treated with bariatric surgery or weight loss medications

artículo científico publicado en 2020

Systematic review and network meta-analysis: first- and second-line biologic therapies for moderate-severe Crohn's disease

artículo científico publicado en 2018

Systematic review with meta-analysis: association between vedolizumab trough concentration and clinical outcomes in patients with inflammatory bowel diseases

scientific article published on 04 September 2019

Systematic review with meta-analysis: prevalence, risk factors and costs of aminosalicylate use in Crohn's disease

scientific article published on 30 May 2018

Systematic review with meta-analysis: safety and tolerability of immune checkpoint inhibitors in patients with pre-existing inflammatory bowel diseases

artículo científico publicado en 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda